“The Integrated 31-Gene Expression Profile Test (i31-GEP) for Cutaneous Melanoma Outperforms the CP-GEP at Identifying Patients who can Forego Sentinel Lymph Node Biopsy when Applying NCCN Guidelines”, J of Skin, vol. 6, no. 6, pp. 474–481, Nov. 2022, doi: 10.25251/skin.6.6.4.